Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
GBP 277M -
Notice Type:
Contract Notice
Published Date:
08 March 2022
Closing Date:
12 April 2022
Location(s):
UK UNITED KINGDOM
UKD NORTH WEST (ENGLAND) (UK UNITED KINGDOM)
Description:
Invitation to offer for NHS London Branded Medicines - Tranche A and Annual

NHS London Branded Medicines - Tranche A

Offer reference number: CM/PHR/20/5614

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.


CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months


CM/PHR/20/5614/02 - NHS Framework for LONDON Branded Medicines - Annual Tranche

CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Download full details as .pdf
The Buyer:
The NHS Commissioning Board (operating under the name of NHS England)
CPV Code(s):
33600000 - Pharmaceutical products